Pharmabiz6m
Vividion Therapeutics doses first patient in phase I study of RAS-PI3Ka inhibitor to treat advanced solid tumours
San Diego, California Friday, April 4, 2025, 16:00 Hrs [IST] ...
Pharmabiz2h
US FDA grants orphan drug designation to Sanofi’s rilzabrutinib, an oral, reversible BTK inhibitor for two rare diseases
US FDA grants orphan drug designation to Sanofi’s rilzabrutinib, an oral, reversible BTK inhibitor for two rare diseases: Paris Friday, April 4, 2025, 14:00 Hrs [IST] The US Foo ...
Pharmabiz1h
Abbott introduces next-generation delivery system to streamline electrode placement during dorsal root ganglion stimulator implantations
Abbott Park, Illinois Friday, April 4, 2025, 15:00 Hrs [IST] ...
Pharmabiz8h
Medical PG and PhD educators urge NMC to reverse discriminatory policy
Medical PG and PhD educators urge NMC to reverse discriminatory policy: Our Bureau, New Delhi Friday, April 4, 2025, 08:00 ...
Pharmabiz3h
MultiOmic Health inks MoU with Alloy Therapeutics to discover and develop renal tissue-targeting drugs
MultiOmic Health inks MoU with Alloy Therapeutics to discover and develop renal tissue-targeting drugs: London Friday, April 4, 2025, 13:00 Hrs [IST] MultiOmic Health Limited, an ...
Pharmabiz4h
CHMP recommends approval for Averoa’s Xoanacyl, an oral therapy for chronic kidney disease
CHMP recommends approval for Averoa’s Xoanacyl, an oral therapy for chronic kidney disease: Grenoble, France Friday, April 4, 2025, 12:00 Hrs [IST] Averoa, a biopharmaceutical c ...
Pharmabiz5h
Roche’s phase III MUSETTE trial of Ocrevus high dose in people with relapsing multiple sclerosis fails to meet primary endpoint
Roche’s phase III MUSETTE trial of Ocrevus high dose in people with relapsing multiple sclerosis fails to meet primary endpoint: Basel Friday, April 4, 2025, 11:00 Hrs [IST] Roc ...
Pharmabiz5h
US tariff exemption to bolster Indian pharma global presence with supply of high quality medicines
US tariff exemption to bolster Indian pharma global presence with supply of high quality medicines: Our Bureau, Bengaluru Friday, April 4, 2025, 10:45 Hrs [IST] Indian pharma brea ...
Pharmabiz6h
Boehringer Ingelheim strengthens antibody-drug conjugate portfolio with new NBE Therapeutics R&D centre in Basel
Basel, Switzerland Friday, April 4, 2025, 10:00 Hrs [IST] ...
Pharmabiz8h
Madhya Pradesh is free from counterfeit and substandard drugs: Dr. Shobhit Khoshta
Madhya Pradesh is free from counterfeit and substandard drugs: Dr. Shobhit Khoshta: Peethaambaran Kunnathoor, Chennai Friday, April 4, 2025, 08:00 Hrs [IST] Dr. Shobhit Khoshta, t ...
Pharmabiz8h
Need for accurate testing solutions are higher than ever as chikungunya outbreaks increase: Dr Sameer Bhati
Shardul Nautiyal, Mumbai Friday, April 4, 2025, 08:00 Hrs [IST] ...
Pharmabiz8h
Lifesciences industry sees significant shifts with digital transformation & increased M&As: Chandra Ambadipudi
Lifesciences industry sees significant shifts with digital transformation & increased M&As: Chandra Ambadipudi: Nandita Vijayasimha, Bengaluru Friday, April 4, 2025, 08:00 Hrs [IS ...